GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lotus Pharmaceutical Co 1795.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

166.50

+0.30%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 20.51bn

FY2016FY2025

Net income

TWD 4.72bn

FY2016FY2025

Free cash flow

TWD 3.13bn

FY2016FY2025

Shareholders' equity

TWD 23.78bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 20.51bnTWD 18.58bnTWD 16.96bnTWD 14.63bnTWD 12.65bnTWD 10.73bnTWD 9.17bnTWD 6.43bnTWD 6.42bnTWD 5.90bn
Gross profitTWD 10.64bnTWD 10.92bnTWD 9.38bnTWD 7.81bnTWD 5.64bnTWD 4.60bnTWD 4.25bnTWD 3.14bnTWD 3.08bnTWD 3.33bn
Research and developmentTWD 986.7mTWD 773.9mTWD 720.8mTWD 520.4mTWD 595.9mTWD 505.4mTWD 553.6mTWD 324.9mTWD 329.5mTWD 452.2m
Operating incomeTWD 5.90bnTWD 6.49bnTWD 5.43bnTWD 4.32bnTWD 2.20bnTWD 1.64bnTWD 1.33bnTWD 448.7mTWD 523.1mTWD 244.4m
Net incomeTWD 4.72bnTWD 5.07bnTWD 4.11bnTWD 3.02bnTWD 1.40bnTWD 1.03bnTWD 662.8mTWD 99.5mTWD 7.7m−TWD 134.0m
Diluted earnings per share17.9619.0915.5211.355.404.242.720.410.03-0.58

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 106.15bnTWD 40.10bnTWD 32.99bnTWD 29.53bnTWD 21.22bnTWD 19.75bnTWD 17.92bnTWD 14.85bnTWD 15.66bnTWD 15.24bn
Cash and short-term investmentsTWD 7.74bnTWD 6.03bnTWD 1.77bnTWD 1.98bnTWD 1.61bnTWD 1.49bnTWD 1.12bnTWD 1.02bnTWD 1.77bnTWD 2.04bn
Total liabilitiesTWD 82.37bnTWD 18.92bnTWD 15.66bnTWD 15.66bnTWD 10.15bnTWD 11.01bnTWD 10.17bnTWD 7.17bnTWD 7.96bnTWD 6.88bn
DebtTWD 46.76bnTWD 13.67bnTWD 11.58bnTWD 8.92bnTWD 6.39bnTWD 6.83bnTWD 4.94bnTWD 2.07bnTWD 4.88bnTWD 4.46bn
Shareholders' equityTWD 23.78bnTWD 21.18bnTWD 17.33bnTWD 13.87bnTWD 11.07bnTWD 8.75bnTWD 7.74bnTWD 7.23bnTWD 7.29bnTWD 7.44bn
Shares outstanding263m265m264m266m260m242m243m241m242m231m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 7.48bnTWD 6.15bnTWD 1.61bnTWD 3.72bnTWD 119.7mTWD 1.95bnTWD 302.8mTWD 797.0mTWD 592.3mTWD 1.23bn
Capital spending−TWD 4.35bn−TWD 1.47bn−TWD 3.28bn−TWD 577.2m−TWD 1.62bn−TWD 2.00bn−TWD 1.10bn−TWD 399.1m−TWD 914.8m−TWD 660.5m
Free cash flowTWD 3.13bnTWD 4.69bn−TWD 1.66bnTWD 3.14bn−TWD 1.50bn−TWD 48.9m−TWD 799.9mTWD 397.9m−TWD 322.5mTWD 572.5m
Dividends paid−TWD 1.52bn−TWD 1.23bn−TWD 906.2m−TWD 506.1m−TWD 92.0m−TWD 92.0m−TWD 92.0m−TWD 92.0m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 8.81bnTWD 8.64bnTWD 6.26bnTWD 4.77bnTWD 4.75bnTWD 4.73bnTWD 4.41bnTWD 5.23bn
Gross profitTWD 4.22bnTWD 3.88bnTWD 2.50bnTWD 2.43bnTWD 2.79bnTWD 2.92bnTWD 2.43bnTWD 3.32bn
Operating incomeTWD 2.33bnTWD 1.91bnTWD 1.49bnTWD 1.29bnTWD 960.4mTWD 1.83bnTWD 1.13bnTWD 2.11bn
Net incomeTWD 642.3mTWD 567.2mTWD 1.12bnTWD 1.43bnTWD 728.3mTWD 1.44bnTWD 1.13bnTWD 1.57bn
Diluted earnings per share2.462.174.275.462.775.464.275.90
Cash from operationsTWD 701.0m−TWD 19.0mTWD 1.35bnTWD 2.47bnTWD 931.0mTWD 2.73bnTWD 1.55bnTWD 1.91bn
Capital spending−TWD 97.0m−TWD 158.0m−TWD 1.60bn−TWD 34.0m−TWD 616.0m−TWD 1.87bn−TWD 480.0m−TWD 286.0m
Free cash flowTWD 604.0m−TWD 177.0m−TWD 255.0mTWD 2.44bnTWD 315.0mTWD 857.0mTWD 1.07bnTWD 1.62bn
Total assetsTWD 108.59bnTWD 107.53bnTWD 106.15bnTWD 39.60bnTWD 38.16bnTWD 40.67bnTWD 40.10bnTWD 37.23bn
Cash and short-term investmentsTWD 6.33bnTWD 6.20bnTWD 7.74bnTWD 5.67bnTWD 4.11bnTWD 5.60bnTWD 6.03bnTWD 3.69bn
DebtTWD 5.82bnTWD 47.22bnTWD 46.76bnTWD 12.27bnTWD 11.47bnTWD 12.23bnTWD 13.47bnTWD 12.22bn
Shareholders' equityTWD 24.31bnTWD 24.03bnTWD 23.78bnTWD 22.17bnTWD 20.36bnTWD 21.20bnTWD 21.18bnTWD 20.22bn

Financial ratios

Data as of 14 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin51.9%58.8%55.3%53.3%44.6%42.8%
Operating margin28.7%34.9%32.0%29.5%17.4%15.3%
Net margin23.0%27.3%24.2%20.6%11.1%9.6%
Return on equity19.8%23.9%23.7%21.8%12.7%11.7%
Return on assets4.4%12.6%12.4%10.2%6.6%5.2%
Free cash flow yield26.0%16.5%10.7%9.3%3.8%9.4%
Revenue growth10.4%9.6%15.9%15.7%17.9%16.9%
Earnings growth-6.8%23.4%35.9%115.3%36.7%54.9%
Current ratio1.57x2.14x2.80x1.81x1.93x1.39x
Debt to equity1.97x0.64x0.66x0.64x0.62x0.77x
Equity ratio22.4%52.8%52.5%47.0%52.2%44.3%
Interest coverage6.59x11.37x9.74x11.29x7.42x4.91x
R&D as a share of sales4.8%4.2%4.3%3.6%4.7%4.7%
Buybacks as a share of market value1.0%-0.4%0.6%-2.4%-7.2%0.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.9%13.8%14.0%
Operating income10.9%29.2%29.4%
Net income16.0%35.7%46.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin55.2%54.8%52.1%51.8%
Operating margin31.7%31.3%27.6%22.7%
Net margin25.0%23.9%20.6%15.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings15.613.917.321.417.818.641.7177.0—-101.8
Price to sales3.63.84.24.42.01.83.02.71.92.3

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 31 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2011FY2010
Paid in the year2.5655.7044.5883.4151.9060.3460.2710.085
  • 1.06-for-1 split · 8 Sept 2010
  • 21-for-20 split · 12 Aug 2009
  • 11-for-10 split · 14 Aug 2008
  • 1.04-for-1 split · 12 Sept 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.